FR2775976B1
(en)
*
|
1998-03-10 |
2000-06-02 |
Fabre Pierre Dermo Cosmetique |
PHARMACEUTICAL OR COSMETIC COMPOSITION CONTAINING AN ACTIVE PRECURSOR HYDROLYSABLE BY GLUCOCEREBROSIDASE
|
FR2808191B1
(en)
*
|
2000-04-28 |
2004-03-05 |
Oreal |
PLANT EXTRACT OF THE SPECIES OLEA EUROPAEA AS NO-SYNTHASE INHIBITOR AND USES
|
TWI287995B
(en)
*
|
2000-05-09 |
2007-10-11 |
Kaneka Corp |
Dermatological composition containing co-enzyme Q as active ingredient
|
US7713569B2
(en)
*
|
2000-09-01 |
2010-05-11 |
Creagri, Inc. |
Hydroxytyrosol-rich composition from olive vegetation water and method of use thereof
|
EP1315691B2
(en)
*
|
2000-09-01 |
2017-09-13 |
Creagri, Inc. |
Method of obtaining a hydroxytyrosol-rich composition from vegetation water
|
US20030206965A1
(en)
*
|
2000-09-29 |
2003-11-06 |
The Procter & Gamble Company |
Allergen neutralization compositions
|
IL158899A0
(en)
*
|
2001-05-23 |
2004-05-12 |
|
Pharmaceutical compositions for inhibiting angiogenesis containing oleuropein and derivatives thereof
|
FR2825022B1
(en)
*
|
2001-05-23 |
2005-01-14 |
Seppic Sa |
COMPOSITION OF OLIVE POLYPHENOLS. USE AS A COSMETIC AND DIETETIC ACTIVE
|
US8216599B2
(en)
*
|
2002-02-13 |
2012-07-10 |
Creagri, Inc. |
Method for treatment of inflammation
|
ES2193874B1
(en)
*
|
2002-04-03 |
2005-03-01 |
Puleva Biotech, S.A. |
NATURAL AND DERIVATIVE COMPOUNDS OF THESE FOR THE PREVENTION AND TREATMENT OF CARDIOVASCULAR, HEPATIC, RENAL AND COSMETIC DISEASES.
|
US7468355B2
(en)
*
|
2002-05-22 |
2008-12-23 |
H2Rc Corporation |
Methods for inhibiting cancer and scar formation
|
AU2003279924A1
(en)
*
|
2002-10-11 |
2004-05-04 |
Creagri, Inc. |
Therapeutic combination of carnitine and antioxidant polyphenols
|
IL152486A0
(en)
|
2002-10-25 |
2003-05-29 |
Meir Eini |
Alcohol-free cosmetic and pharmaceutical foam carrier
|
US20160158261A1
(en)
*
|
2002-10-25 |
2016-06-09 |
Foamix Pharmaceuticals Ltd. |
Antibiotic Kit and Composition and Uses Thereof
|
US9265725B2
(en)
|
2002-10-25 |
2016-02-23 |
Foamix Pharmaceuticals Ltd. |
Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
|
US10117812B2
(en)
|
2002-10-25 |
2018-11-06 |
Foamix Pharmaceuticals Ltd. |
Foamable composition combining a polar solvent and a hydrophobic carrier
|
FR2853549B1
(en)
*
|
2003-04-11 |
2007-11-09 |
Agronomique Inst Nat Rech |
NUTRITIONAL OR THERAPEUTIC COMPOSITION CONTAINING THE OLEUROPE COMPOUND OR ONE OF ITS DERIVATIVES
|
KR20050007883A
(en)
*
|
2003-07-12 |
2005-01-21 |
(주)현덕비엔티 |
Composition for anti-phototoxic effect on skin comprising polyphenol purified from green tea, and ascorbic acid and its derivatives
|
US7205011B2
(en)
*
|
2003-11-14 |
2007-04-17 |
Board Of Regents, Acting For And On Behalf Of, University Of Arizona |
Anti-inflammatory activity of a specific turmeric extract
|
FR2864785B1
(en)
*
|
2004-01-06 |
2006-02-10 |
Oreal |
COSMETIC COMPOSITION COMPRISING AN EXTRACT OF OLIVE SHEET AND A VEGETATION EXTRACT FROM OLIVES
|
US20080234225A1
(en)
*
|
2004-03-15 |
2008-09-25 |
John Lezdey |
Method of treatment
|
KR100868905B1
(en)
*
|
2004-03-26 |
2008-11-14 |
(주)아모레퍼시픽 |
Composition for preventing UVB-induced skin damage by treating both Gensenoside F1 and EGCG
|
US20080300198A1
(en)
*
|
2004-08-09 |
2008-12-04 |
Kathleen Matt |
Olive Compositions and Methods for Treating Inflammatory Conditions
|
US8252321B2
(en)
|
2004-09-13 |
2012-08-28 |
Chrono Therapeutics, Inc. |
Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
|
JP5254616B2
(en)
|
2004-09-13 |
2013-08-07 |
クロノ セラピューティクス、インコーポレイテッド |
Biosynchronous transdermal drug delivery
|
MX2007003126A
(en)
|
2004-09-14 |
2007-08-02 |
Ajinomoto Omnichem S A |
Topical compositions containing phosphorylated polyphenols.
|
US20070042026A1
(en)
*
|
2005-03-17 |
2007-02-22 |
Wille John J |
Prophylactic and therapeutic treatment of topical and transdermal drug-induced skin reactions
|
US7252834B2
(en)
*
|
2005-04-25 |
2007-08-07 |
Clemson University Research Foundation (Curf) |
Elastin stabilization of connective tissue
|
US8372040B2
(en)
|
2005-05-24 |
2013-02-12 |
Chrono Therapeutics, Inc. |
Portable drug delivery device including a detachable and replaceable administration or dosing element
|
US9789149B2
(en)
*
|
2005-07-19 |
2017-10-17 |
Creagri, Inc. |
Vegetation water composition for treatment of inflammatory skin conditions
|
ES2291111B1
(en)
*
|
2006-02-17 |
2009-03-16 |
Universidad De Granada |
PROCEDURE FOR THE INDUSTRIAL USE OF TIROSOL AND HYDROXYTIROSOL CONTAINED IN THE SOLID SUBPRODUCTS OF THE INDUSTRIAL MOLTURATION OF THE OLIVE.
|
WO2008006582A1
(en)
*
|
2006-07-14 |
2008-01-17 |
Dsm Ip Assets B.V. |
Compositions comprising magnolol or honokiol and other active agents for the treatment of inflammatory diseases
|
EP2040696B1
(en)
*
|
2006-07-14 |
2017-01-25 |
DSM IP Assets B.V. |
Compositions and use thereof for the treatment, co-treatment or prevention of inflammatory disorders
|
KR20090033470A
(en)
*
|
2006-07-14 |
2009-04-03 |
디에스엠 아이피 어셋츠 비.브이. |
Compositions comprising rosehip and other active agents for the treatment of inflammatory disorders
|
FR2912055B1
(en)
*
|
2007-02-06 |
2009-05-15 |
Idenov Lab |
COSMETIC COMPOSITION COMPRISING ANTI-INFLAMMATORY, REPAIRING, SOOTHING AND MOISTURIZING ACTIVE INGREDIENTS FOR CALMING SKIN IRRITATION
|
EP1982707A1
(en)
*
|
2007-04-18 |
2008-10-22 |
DSMIP Assets B.V. |
Use of hydroxytyrosol as anti-aging agent
|
US8617544B2
(en)
*
|
2007-05-01 |
2013-12-31 |
Richard L. Kozlenko |
Compositions and methods for controlling lipid metabolism
|
FR2918278B1
(en)
*
|
2007-07-04 |
2009-11-20 |
Girex |
USE OF OLEOCANTHAL IN THE TREATMENT OF SKIN INFLAMMATION.
|
US8636982B2
(en)
|
2007-08-07 |
2014-01-28 |
Foamix Ltd. |
Wax foamable vehicle and pharmaceutical compositions thereof
|
US20090155337A1
(en)
*
|
2007-11-12 |
2009-06-18 |
Endologix, Inc. |
Method and agent for in-situ stabilization of vascular tissue
|
WO2009072007A2
(en)
|
2007-12-07 |
2009-06-11 |
Foamix Ltd. |
Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
|
JP2011513220A
(en)
*
|
2008-02-21 |
2011-04-28 |
ヴァトリックス・メディカル・インコーポレーテッド |
Treatment of aneurysms by application of connective tissue stabilizer in combination with delivery vehicle
|
US8071139B2
(en)
*
|
2008-09-04 |
2011-12-06 |
Alan David Widgerow |
Treatment of damaged skin
|
US8591961B2
(en)
|
2008-09-04 |
2013-11-26 |
Allergan, Inc. |
Aesthetic treatment of scars and aging skin
|
US20100016833A1
(en)
*
|
2008-07-15 |
2010-01-21 |
Ogle Matthew F |
Devices for the Treatment of Vascular Aneurysm
|
US20100119605A1
(en)
*
|
2008-11-12 |
2010-05-13 |
Isenburg Jason C |
Compositions for tissue stabilization
|
CA2760186C
(en)
|
2009-04-28 |
2019-10-29 |
Foamix Ltd. |
Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
|
US8809311B2
(en)
|
2009-08-10 |
2014-08-19 |
Darlene McCord |
Nutritional supplements
|
US8796315B2
(en)
|
2009-06-25 |
2014-08-05 |
Darlene E. McCord |
Methods for improved wound closure employing olivamine and human umbilical vein endothelial cells
|
CA2764060C
(en)
*
|
2009-06-25 |
2015-08-25 |
Darlene Mccord |
Topical compositions and methods for wound care
|
US8496911B2
(en)
*
|
2009-07-29 |
2013-07-30 |
Vatrix CHF, Inc. |
Tissue stabilization for heart failure
|
WO2011013009A2
(en)
|
2009-07-29 |
2011-02-03 |
Foamix Ltd. |
Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
|
CA2769677A1
(en)
|
2009-07-29 |
2011-02-03 |
Foamix Ltd. |
Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
|
US8663608B2
(en)
|
2009-09-22 |
2014-03-04 |
University Of Cape Town |
Hydroxytyrosol compounds
|
US9849142B2
(en)
|
2009-10-02 |
2017-12-26 |
Foamix Pharmaceuticals Ltd. |
Methods for accelerated return of skin integrity and for the treatment of impetigo
|
WO2011039638A2
(en)
|
2009-10-02 |
2011-04-07 |
Foamix Ltd. |
Topical tetracycline compositions
|
US20110218517A1
(en)
*
|
2009-10-09 |
2011-09-08 |
Ogle Matthew F |
In vivo chemical stabilization of vulnerable plaque
|
US8444624B2
(en)
|
2009-10-19 |
2013-05-21 |
Vatrix Medical, Inc. |
Vascular medical devices with sealing elements and procedures for the treatment of isolated vessel sections
|
US8580742B2
(en)
|
2010-03-05 |
2013-11-12 |
N.V. Perricone Llc |
Topical glutathione formulations for menopausal skin
|
US8609604B2
(en)
|
2009-12-28 |
2013-12-17 |
N.V. Perricone Llc |
Methods of improving the appearance of aging skin
|
US20110160144A1
(en)
*
|
2009-12-28 |
2011-06-30 |
Perricone Nicholas V |
Topical Acyl Glutathione Formulations
|
CA2785633C
(en)
|
2009-12-28 |
2014-07-15 |
N.V. Perricone Llc |
Topical acyl glutathione formulations
|
US20110245182A1
(en)
|
2010-04-06 |
2011-10-06 |
Perricone Nicholas V |
Topical Uses of Szeto-Schiller Peptides
|
US20110245183A1
(en)
|
2010-04-06 |
2011-10-06 |
Perricone Nicholas V |
Topical Uses of Szeto-Schiller Peptides
|
US20120083452A1
(en)
|
2010-09-30 |
2012-04-05 |
Perricone Nicholas V |
Topical Anesthetic Uses of Szeto-Schiller Peptides
|
US8414869B2
(en)
|
2010-11-30 |
2013-04-09 |
N.V. Perricone Llc |
Melanin promoting topical composition
|
US8911468B2
(en)
|
2011-01-31 |
2014-12-16 |
Vatrix Medical, Inc. |
Devices, therapeutic compositions and corresponding percutaneous treatment methods for aortic dissection
|
US8609618B2
(en)
|
2011-03-25 |
2013-12-17 |
N.V. Perricone Llc |
Topical palmitoyl glutathione formulations
|
JP2014516695A
(en)
|
2011-05-18 |
2014-07-17 |
バトリックス・メディカル・インコーポレイテッド |
Coated balloon for vascular stabilization
|
US20130017259A1
(en)
|
2011-07-06 |
2013-01-17 |
The Parkinson's Institute |
Compositions and Methods for Treatment of Symptoms in Parkinson's Disease Patients
|
US9283241B2
(en)
|
2012-07-10 |
2016-03-15 |
Clemson University |
Treatment to render implants resistant to diabetes
|
EP2925307B1
(en)
|
2012-11-30 |
2020-10-28 |
McCord, Darlene E. |
Hydroxytyrosol and oleuropein compositions for induction of dna damage, cell death and lsd1 inhibition
|
US10105487B2
(en)
|
2013-01-24 |
2018-10-23 |
Chrono Therapeutics Inc. |
Optimized bio-synchronous bioactive agent delivery system
|
WO2014150174A1
(en)
*
|
2013-03-15 |
2014-09-25 |
Mccord Darlene E |
Methods for improved wound closure employing olivamine and human umbilical vein endothelial cells
|
CA2934104C
(en)
*
|
2013-12-23 |
2022-09-27 |
Medical Brands Research B.V. |
Dermatological composition based on algae and olive leaf extracts
|
CN103893237B
(en)
*
|
2014-04-14 |
2016-08-17 |
成都一平医药科技发展有限公司 |
A kind of containing Cornu Cervi Pantotrichum with the compositions of Fructus Canarii albi extract
|
CA2974324A1
(en)
|
2015-01-28 |
2016-08-04 |
Zita S. Netzel |
Drug delivery methods and systems
|
WO2016145373A1
(en)
|
2015-03-12 |
2016-09-15 |
Chrono Therapeutics Inc. |
Craving input and support system
|
US10398641B2
(en)
|
2016-09-08 |
2019-09-03 |
Foamix Pharmaceuticals Ltd. |
Compositions and methods for treating rosacea and acne
|
KR101839109B1
(en)
*
|
2016-09-22 |
2018-03-15 |
㈜프론트바이오 |
Composition for preventing or treating skin disease, comprising extract of purple corn
|
AU2018205529B2
(en)
|
2017-01-06 |
2023-08-10 |
Morningside Venture Investments Limited |
Transdermal drug delivery devices and methods
|
JP7420797B2
(en)
|
2018-05-29 |
2024-01-23 |
モーニングサイド ベンチャー インベストメンツ リミテッド |
Drug delivery methods and systems
|
WO2022079637A1
(en)
*
|
2020-10-13 |
2022-04-21 |
Attica Sciences Ltd. |
Analogues of oleuropein and oleacein and uses thereof
|
IT202200009722A1
(en)
*
|
2022-05-11 |
2023-11-11 |
Active Italia S R L |
“Preparation based on olive oil polyphenols in eutectic solvents and their use
|